Four New York Times reporters pressed Mr. Trump about a range of topics in a nearly two-hour interview. Here is a transcript ...

One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for ...

The Ethereum co-founder argues that price benchmarks, oracle security and staking incentives remain unresolved challenges for ...

Well, it happened again. Just about the beginning of every new year, someone will say, “You have lived a long time, Mr. Bill.